Page last updated: 2024-10-28

ha14-1 and Lymphoma, Mantle-Cell

ha14-1 has been researched along with Lymphoma, Mantle-Cell in 1 studies

ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia

Lymphoma, Mantle-Cell: A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN D1 gene (GENES, BCL-1).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campàs, C1
Cosialls, AM1
Barragán, M1
Iglesias-Serret, D1
Santidrián, AF1
Coll-Mulet, L1
de Frias, M1
Domingo, A1
Pons, G1
Gil, J1

Other Studies

1 other study available for ha14-1 and Lymphoma, Mantle-Cell

ArticleYear
Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
    Experimental hematology, 2006, Volume: 34, Issue:12

    Topics: Antimycin A; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzopyrans; Cell Survival;

2006